Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIXTM

Theo Nicholaou; Weisan Chen; Ian Davis; Heather Jackson; Nektaria Dimopoulos; Catherine Barrow; Judy Browning; Duncan McGregor; David Williams; Wendie Hopkins; Eugene Maraskovsky; Ralph Venhaus; Linda Pan; Eric W Hoffman; Lloyd J Old; Jonathan Cebon

doi:10.1007/s00262-011-1041-3

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX^TM

Theo Nicholaou, Weisan Chen, Ian Davis, Heather Jackson, Nektaria Dimopoulos, Catherine Barrow, Judy Browning, Duncan McGregor, David Williams, Wendie Hopkins, Eugene Maraskovsky, Ralph Venhaus, Linda Pan, Eric W Hoffman, Lloyd J Old, Jonathan Cebon

Eastern Health Clinical School

Research output: Contribution to journal › Article › Research › peer-review

39 Citations (Scopus)

Original language	English
Pages (from-to)	1625 - 1637
Number of pages	13
Journal	Cancer Immunology Immunotherapy
Volume	60
Issue number	11
DOIs	https://doi.org/10.1007/s00262-011-1041-3
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00262-011-1041-3

Cite this

Nicholaou, T., Chen, W., Davis, I., Jackson, H., Dimopoulos, N., Barrow, C., Browning, J., McGregor, D., Williams, D., Hopkins, W., Maraskovsky, E., Venhaus, R., Pan, L., Hoffman, E. W., Old, L. J., & Cebon, J. (2011). Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX^TM. Cancer Immunology Immunotherapy, 60(11), 1625 - 1637. https://doi.org/10.1007/s00262-011-1041-3

@article{af5d17345cec4e888f67354b7b4a0d94,

title = "Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIXTM",

author = "Theo Nicholaou and Weisan Chen and Ian Davis and Heather Jackson and Nektaria Dimopoulos and Catherine Barrow and Judy Browning and Duncan McGregor and David Williams and Wendie Hopkins and Eugene Maraskovsky and Ralph Venhaus and Linda Pan and Hoffman, {Eric W} and Old, {Lloyd J} and Jonathan Cebon",

year = "2011",

doi = "10.1007/s00262-011-1041-3",

language = "English",

volume = "60",

pages = "1625 -- 1637",

journal = "Cancer Immunology Immunotherapy",

issn = "0340-7004",

publisher = "Springer-Verlag London Ltd.",

number = "11",

}

Nicholaou, T, Chen, W, Davis, I, Jackson, H, Dimopoulos, N, Barrow, C, Browning, J, McGregor, D, Williams, D, Hopkins, W, Maraskovsky, E, Venhaus, R, Pan, L, Hoffman, EW, Old, LJ & Cebon, J 2011, 'Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX^TM', Cancer Immunology Immunotherapy, vol. 60, no. 11, pp. 1625 - 1637. https://doi.org/10.1007/s00262-011-1041-3

TY - JOUR

T1 - Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIXTM

AU - Nicholaou, Theo

AU - Chen, Weisan

AU - Davis, Ian

AU - Jackson, Heather

AU - Dimopoulos, Nektaria

AU - Barrow, Catherine

AU - Browning, Judy

AU - McGregor, Duncan

AU - Williams, David

AU - Hopkins, Wendie

AU - Maraskovsky, Eugene

AU - Venhaus, Ralph

AU - Pan, Linda

AU - Hoffman, Eric W

AU - Old, Lloyd J

AU - Cebon, Jonathan

PY - 2011

Y1 - 2011

U2 - 10.1007/s00262-011-1041-3

DO - 10.1007/s00262-011-1041-3

M3 - Article

VL - 60

SP - 1625

EP - 1637

JO - Cancer Immunology Immunotherapy

JF - Cancer Immunology Immunotherapy

SN - 0340-7004

IS - 11

ER -